Cspc Pharmaceutical Group

(OTC) CSPCY

Current Price$4.30

Market Cap$12.39B

Since IPO (2018)+69%

5 Year+2%

1 Year+45%

1 Month-16%

Cspc Pharmaceutical Group Financials at a Glance

Market Cap

$12.39B

Revenue (TTM)

$46.61B

Net Income (TTM)

$6.41B

EPS (TTM)

$0.19

P/E Ratio

22.84

Dividend

$0.12

Beta (Volatility)

0.47 (Low)

Dividend

$0.12

Beta (Volatility)

0.47 (Low)

Price

$4.30

Volume

365

Open

$4.34

Price

$4.30

Volume

365

Open

$4.34

Previous Close

$4.30

Daily Range

$4.30 - $4.34

52-Week Range

$2.73 - $5.83

Dividend

$0.12

Beta (Volatility)

0.47 (Low)

Price

$4.30

Volume

365

Open

$4.34

Previous Close

$4.30

Daily Range

$4.30 - $4.34

52-Week Range

$2.73 - $5.83

CSPCY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cspc Pharmaceutical Group

Industry

Pharmaceuticals

Sector

Health Care

Employees

19,700

CEO

Lei Cai, PhD

Website

www.cspc.com.hk

Headquarters

Shijiazhuang, 050035, CN

CSPCY Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

15%

Net Income Margin

15%

Return on Equity

12%

Return on Capital

11%

Return on Assets

Earnings Yield

4.38%

Dividend Yield

2.85%

Payout Ratio

65.13%

Stock Overview

Market Cap

$12.39B

Shares Outstanding

2.88B

Volume

365

Avg. Volume

3.92K

Financials (TTM)

Gross Profit

$18.47B

Operating Income

$4.30B

EBITDA

$5.83B

Operating Cash Flow

$5.83B

Capital Expenditure

$2.28B

Free Cash Flow

$3.55B

Cash & ST Invst.

$9.87B

Total Debt

$714.01M

Cspc Pharmaceutical Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$13.91B

+83.4%

Gross Profit

$9.12B

-51.2%

Gross Margin

65.57%

N/A

Market Cap

$12.39B

N/A

Market Cap/Employee

$578.82K

N/A

Employees

21,400

N/A

Net Income

$1.46B

+5.7%

EBITDA

$2.32B

+29.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$9.16B

-26.0%

Accounts Receivable

$10.63B

+5.0%

Inventory

$3.44B

-0.3%

Long Term Debt

$201.24M

+88.0%

Short Term Debt

$512.77M

-14.5%

Return on Assets

8.07%

N/A

Return on Invested Capital

10.56%

N/A

Free Cash Flow

$2.22B

+13.2%

Operating Cash Flow

$3.07B

-2.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ERFSFEurofins Scientific SE

ERFSFEurofins Scientific SE$70.95+5.16%

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.$55.88+0.00%

BDULFBangkok Dusit Medical Services Public Company Limited

BDULFBangkok Dusit Medical Services Public Company Limited$0.66+0.00%

BDUUFBangkok Dusit Medical Services Public Company Limited

BDUUFBangkok Dusit Medical Services Public Company Limited$0.65+0.00%

BIOVFSwedish Orphan Biovitrum AB (publ)

BIOVFSwedish Orphan Biovitrum AB (publ)$47.35+9.73%

GIFLFGrifols, S.A.

GIFLFGrifols, S.A.$10.57+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CSPCY

What is the current price of Cspc Pharmaceutical Group?

Cspc Pharmaceutical Group is trading at $4.30 per share.

What is the 52-week range for Cspc Pharmaceutical Group?

Over the past 52 weeks, Cspc Pharmaceutical Group has traded between $2.73 and $5.83.

How much debt does Cspc Pharmaceutical Group have?

As of the most recent reporting period, Cspc Pharmaceutical Group reported total debt of $91.74M.

How much cash does Cspc Pharmaceutical Group have on hand?

Cspc Pharmaceutical Group reported $754.52M in cash and cash equivalents in its most recent financial results.

What is Cspc Pharmaceutical Group’s dividend yield?

Cspc Pharmaceutical Group currently has a dividend yield of 2.85%.

Cspc Pharmaceutical Group

Cspc Pharmaceutical Group Financials at a Glance

CSPCY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cspc Pharmaceutical Group

CSPCY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cspc Pharmaceutical Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CSPCY

What is the current price of Cspc Pharmaceutical Group?

What is the 52-week range for Cspc Pharmaceutical Group?

How much debt does Cspc Pharmaceutical Group have?

How much cash does Cspc Pharmaceutical Group have on hand?

What is Cspc Pharmaceutical Group’s dividend yield?

Premium Investing Services